Mari Kogiso
Children's Nutrition Research Center at Baylor College of Medicine(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Research and Treatments, Cancer, Hypoxia, and Metabolism, Nanoplatforms for cancer theranostics, Virus-based gene therapy research
Most-Cited Works
- → Functionally defined therapeutic targets in diffuse intrinsic pontine glioma(2015)697 cited
- → RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma(2020)41 cited
- → BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA(2015)4 cited
- → Abstract 1484: CD57 defines a novel maker of glioblastoma stem cells that have greater invasive potential than CD133+ tumor cells(2014)1 cited
- → LG-21IN VIVO EVOLUTION OF A NOVEL PATIENT-DERIVED ORTHOTOPIC XENOGRAFT (PDOX) MOUSE MODELS OF PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA HARBORING BRAF V600E MUTATION(2016)1 cited
- → CBIO-34MiR-126 AND miR-369-5p ARE DRIVERS OF GBM INVASION: AN IN VIVO STUDY IN PATIENT-TUMOR DERIVED ORTHOTOPIC XENOGRAFT MOUSE MODELS(2015)1 cited
- → Dissection, Histological Processing, and Gene Expression Analysis of Murine Supraclavicular Brown Adipose Tissue(2024)
- → P11.08 Systematic drug repurposing for faster cures of pediatric cancer identifies that Digoxin prolongs survival in a PDOX model of group 4 medulloblastoma(2017)
- → PDTM-07. SYSTEMATIC DRUG IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES(2017)
- → Corrigendum to “Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors” [Cancer Lett. 493 (2020) 197–206](2020)